SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024523
Filing Date
2020-05-12
Accepted
2020-05-12 11:10:45
Documents
42
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q evok-10q_20200331.htm 10-Q 738199
2 EX-10.1 evok-ex101_205.htm EX-10.1 424772
3 EX-10.2 evok-ex102_206.htm EX-10.2 79409
4 EX-10.3 evok-ex103_204.htm EX-10.3 33003
5 EX-31.1 evok-ex311_10.htm EX-31.1 9580
6 EX-31.2 evok-ex312_8.htm EX-31.2 9861
7 EX-32.1 evok-ex321_6.htm EX-32.1 5029
8 EX-32.2 evok-ex322_9.htm EX-32.2 5248
  Complete submission text file 0001564590-20-024523.txt   2864151

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT evok-20200331.xml EX-101.INS 348309
10 XBRL TAXONOMY EXTENSION SCHEMA evok-20200331.xsd EX-101.SCH 26134
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE evok-20200331_cal.xml EX-101.CAL 15212
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE evok-20200331_def.xml EX-101.DEF 78285
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE evok-20200331_lab.xml EX-101.LAB 184208
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE evok-20200331_pre.xml EX-101.PRE 139010
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36075 | Film No.: 20867550
SIC: 2834 Pharmaceutical Preparations